284 related articles for article (PubMed ID: 6356902)
1. Step II treatment with labetalol for essential hypertension.
Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
[TBL] [Abstract][Full Text] [Related]
2. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
Frishman WH; Michelson EL; Johnson BF; Poland MP
Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
[TBL] [Abstract][Full Text] [Related]
3. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990
[TBL] [Abstract][Full Text] [Related]
4. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
Davidov ME; Moir GD; Poland MP; Maloy J; Medakovic M
Am J Med; 1983 Oct; 75(4A):47-53. PubMed ID: 6356899
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.
Lucas C; Jenkins P; Mendels J; Due D; Forbes WP; Sirgo MA
J Natl Med Assoc; 1991 Oct; 83(10):866-71. PubMed ID: 1800760
[TBL] [Abstract][Full Text] [Related]
6. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.
Michelson EL; Frishman WH; Lewis JE; Edwards WT; Flanigan WJ; Bloomfield SS; Johnson BF; Lucas C; Freis ED; Finnerty FA
Am J Med; 1983 Oct; 75(4A):68-80. PubMed ID: 6356901
[TBL] [Abstract][Full Text] [Related]
7. Concomitant therapy with labetalol and hydrochlorothiazide in moderate to moderately severe essential hypertension.
Kochar MS; Tyson J; Kalbfleisch JH
J Clin Pharmacol; 1985 Sep; 25(6):433-6. PubMed ID: 3902912
[TBL] [Abstract][Full Text] [Related]
8. Comparison of labetalol and hydrochlorothiazide in elderly patients with hypertension using 24-hour ambulatory blood pressure monitoring.
Weidler DJ; Vidt DG; Toth PD; Due DL; Sirgo MA
J Clin Pharmacol; 1990 Jun; 30(6):524-32. PubMed ID: 2355103
[TBL] [Abstract][Full Text] [Related]
9. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
Ollivier JP; Durier P; Bussiere JL; Gayet JL
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S164-6. PubMed ID: 1974509
[TBL] [Abstract][Full Text] [Related]
12. Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients.
Townsend RR; DiPette DJ; Goodman R; Blumfield D; Cronin R; Gradman A; Katz LA; McCarthy EP; Sopko G
Clin Pharmacol Ther; 1990 Dec; 48(6):665-75. PubMed ID: 2249378
[TBL] [Abstract][Full Text] [Related]
13. Treatment of severe hypertension with labetalol compared with methyldopa and furosemide. Results of a long-term, double-blind, multicenter trial.
Wallin JD; Wilson D; Winer N; Maronde RF; Michelson EL; Langford H; Maloy J; Poland M
Am J Med; 1983 Oct; 75(4A):87-94. PubMed ID: 6356903
[TBL] [Abstract][Full Text] [Related]
14. Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension: results of 24-hour ambulatory blood pressure monitoring.
Applegate WB; Borhani N; DeQuattro V; Kaihlanen PM; Oishi S; Due DL; Sirgo MA
Am J Med; 1991 Feb; 90(2):198-205. PubMed ID: 1996588
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.
Frishman WH; Zawada ET; Smith LK; Sowers J; Swartz SL; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H
Am J Cardiol; 1987 Mar; 59(6):615-23. PubMed ID: 3548301
[TBL] [Abstract][Full Text] [Related]
16. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension.
Gonzalez ER; Peterson MA; Racht EM; Ornato JP; Due DL
Ann Emerg Med; 1991 Apr; 20(4):333-8. PubMed ID: 2003657
[TBL] [Abstract][Full Text] [Related]
17. Treatment of mild and moderate hypertension with medroxalol, an alpha- and beta-adrenergic antagonist.
Schechter PJ; Tanskanen A; Tuomilehto J; Koch-Weser J
J Cardiovasc Pharmacol; 1982; 4(6):955-9. PubMed ID: 6185788
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of labetalol and hydrochlorothiazide on the ventilatory function of hypertensive patients with mild chronic obstructive pulmonary disease.
Light RW; Chetty KG; Stansbury DW
Am J Med; 1983 Oct; 75(4A):109-14. PubMed ID: 6356897
[TBL] [Abstract][Full Text] [Related]
19. Labetalol in the treatment of hypertension in elderly and younger patients.
Abernethy DR; Bartos P; Plachetka JR
J Clin Pharmacol; 1987 Nov; 27(11):902-6. PubMed ID: 2892866
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
Pugsley DJ; Nassim M; Armstrong BK; Beilin L
Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
